Results 231 to 240 of about 39,064 (303)

A European perspective on the market accessibility of biosimilars

, 2012
Paul Declerck, Steven Simoens
openalex   +2 more sources

Budget Impact Analysis of Biosimilar Infliximab Treatment for Rheumatoid Arthritis in Six Central European Countries [PDF]

, 2013
Valentin Brodszky, Márta Péntek, Petra Baji, Orsolya Balogh, N. V. Hevér, László Gulàcsi   +5 more
openalex   +1 more source

Switch acceptance and persistence of adalimumab biosimilars in IBD patients: a prospective observational study. [PDF]

Therap Adv Gastroenterol
D'Abbundo G, Nachury M, Wartski A, Blondeaux A, Hambli S, Gérard R, Desreumaux P, Duveau N, Wils P.   +8 more
europepmc   +1 more source

Introduction of an Infliximab Biosimilar (CT-P13): A Five-Year Budget Impact Analysis for the Treatment of Rheumatoid Arthritis in Ireland [PDF]

, 2013
Géraldine McCarthy, Caty Ebel Bitoun, Hajj-Boutros Guy   +2 more
openalex   +1 more source

Real-World Evidence Assessing the Safety of Administering Intravenous Rituximab Biosimilar in the First Cycle and Subcutaneous Rituximab in Subsequent Cycles in B-Cell Lymphoma Patients. [PDF]

Pharmacy (Basel)
Almandeel T, Khan MA, Algethami A, Alaboud MS, Alkathiri MA, Aseeri M, Absi A, Almansour M, Alotaibi A.   +8 more
europepmc   +1 more source

ECCO position statement: The use of biosimilar medicines in the treatment of inflammatory bowel disease (IBD) [PDF]

, 2013
Silvio Danese, Fernando Gomollón
openalex   +1 more source

Characterization of Biosimilar Monoclonal Antibodies and Their Reference Products Approved in Japan to Reveal the Quality Characteristics in Post-approval Phase. [PDF]

BioDrugs
Shibata H, Harazono A, Kiyoshi M, Saito Y, Ishii-Watabe A.   +4 more
europepmc   +1 more source

Health Canada/BIOTECanada Summit on regulatory and clinical topics related to subsequent entry biologics (biosimilars), Ottawa, Canada, 14 May 2012

, 2012
Jonathan Kay, Brian G. Feagan, Micheal Guirguis, Edward Keystone, Ágnes Klein, A. S. Lubiniecki, Diane R. Mould, Kwasi A. Nyarko, Anthony A.G. Ridgway, Maureen Trudeau, Jian Wang   +10 more
openalex   +1 more source

Mobilization of PBSC for allogeneic transplantation by the use of the G-CSF biosimilar XM02 in healthy donors [PDF]

, 2013
Michael Schmitt, Xiangdong Xu, Inken Hilgendorf, C Schneider, K Borchert, Dietrich Gläser, Mathias Freund, Anita Schmitt   +7 more
openalex   +1 more source

Biosimilar monoclonal antibodies—challenges and opportunities in Europe [PDF]

, 2013
Andrea Laslop
openalex   +1 more source